Morindone from Morinda citrifolia as a potential antiproliferative agent against colorectal cancer cell lines

There is an increasing demand in developing new, effective, and affordable anti-cancer against colon and rectal. In this study, our aim is to identify the potential anthraquinone compounds from the root bark of Morinda citrifolia to be tested in vitro against colorectal cancer cell lines. Eight potential anthraquinone compounds were successfully isolated, purified and tested for both in-silico and in-vitro analyses. Based on the in-silico prediction, two anthraquinones, morindone and rubiadin, exhibit a comparable binding affinity towards multitargets of β-catenin, MDM2-p53 and KRAS. Subsequently, we constructed a 2D interaction analysis based on the above results and it suggests that the predicted anthraquinones from Morinda citrifolia offer an attractive starting point for potential antiproliferative agents against colorectal cancer. In vitro analyses further indicated that morindone and damnacanthal have significant cytotoxicity effect and selectivity activity against colorectal cancer cell lines.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

PloS one - 17(2022), 7 vom: 27., Seite e0270970

Sprache:

Englisch

Beteiligte Personen:

Chee, Cheok Wui [VerfasserIn]
Zamakshshari, Nor Hisam [VerfasserIn]
Lee, Vannajan Sanghiran [VerfasserIn]
Abdullah, Iskandar [VerfasserIn]
Othman, Rozana [VerfasserIn]
Lee, Yean Kee [VerfasserIn]
Mohd Hashim, Najihah [VerfasserIn]
Nor Rashid, Nurshamimi [VerfasserIn]

Links:

Volltext

Themen:

Anthraquinones
Journal Article
Morindone
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 14.07.2022

Date Revised 27.07.2022

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0270970

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM343403358